Office of Research and Development, Department of Veterans Affairs.
Notice of Government owned invention available for licensing.
The invention listed below is owned by the U.S. Government as represented by the Department of Veterans Affairs (VA), and is available for licensing in accordance with 35 U.S.C. 207 and 37 CFR part 404 or Cooperative Research and Development Agreements (CRADA) Collaboration under 15 U.S.C. 3710a to achieve expeditious commercialization of results of Federally-funded research and development. Foreign patents are filed on selected inventions to extend market coverage for U.S. companies and may also be available for licensing.Start Further Info
FOR FURTHER INFORMATION CONTACT:
Technical and licensing information on the invention may be obtained by writing to: Saleem J. Sheredos, Department of Veterans Affairs, Acting Director Technology Transfer Program, Office of Research and Development, 810 Vermont Avenue, NW., Washington, DC 20420; fax: (410) 962-2141; e-mail at: email@example.com. Any request for information should include the Number and Title for the relevant invention as indicated below. Issued patents may be obtained from the Commissioner of Patents, U.S. Patent and Trademark Office, Washington, DC 20231.End Further Info End Preamble Start Supplemental Information
The invention available for licensing is: US Provisional Patent Application No. 60/555,625 “Cardioprotective Effect of Recombinant Human Erythropoietin.”Start Signature
Dated: June 7, 2005.
R. James Nicholson,
Secretary, Department of Veterans Affairs.
[FR Doc. E5-3045 Filed 6-10-05; 8:45 am]
BILLING CODE 8320-01-P